RNA Therapeutics
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
40
NCT06497010
An Exploratory Study of Individualized Neo-antigen mRNA Cancer Vaccine InnoPCV in Advanced Solid Tumor Treatment
Phase: Early Phase 1
Role: Collaborator
Start: Aug 29, 2024
Completion: Dec 31, 2026
Loading map...